Results 221 to 230 of about 65,857 (300)

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Minimally invasive versus conventional mitral valve surgery: a systematic review and meta-analysis of randomised clinical trials. [PDF]

Open Heart
Spadini FA, Lira KB, Delvaux RS, Kopittke L, Anschau F, Ceron RO, Rode J, Rey RAW, Almeida AS.   +8 more
europepmc   +1 more source

A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on Dasatinib

Echocardiography, Volume 43, Issue 6, June 2026.
In a retrospective cohort of 199 adult patients with CML on Dasatinib in a single quaternary center, approximately 25% patients had routine baseline and follow‐up echocardiogram. Dasatinib was associated with significant changes in structural and diastolic parameters.
Chen Chen, Vinesh Appadurai, Maria Paulina Hernandez, Jessica Altman, Nausheen Akhter   +4 more
wiley   +1 more source

Impact of mitral annular calcification in mitral valve surgery: 25-year Mayo Clinic experience. [PDF]

Ann Cardiothorac Surg
Arghami A, Banivaheb B, Schaff HV.
europepmc   +1 more source

Changes in Echocardiographic Parameters of Cardiac Function Following Parathyroidectomy: A Meta‐Analysis

Echocardiography, Volume 43, Issue 6, June 2026.
Patients with symptomatic primary hyperparathyroidism (PHPT) have increased cardiovascular risk related to biochemical abnormalities and structural cardiac changes. We performed a meta‑analysis of 24 studies (881 patients) to evaluate echocardiographic changes following parathyroidectomy. Global longitudinal strain significantly improved after surgery,
Arsalan Anees, Femi E. Ayeni, Senarath Edirimanne   +2 more
wiley   +1 more source

A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)

The Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.
ABSTRACT Hypertension is a prevalent and significant risk factor for cardiovascular disease (CVD). The immune system and inflammatory response are involved in the pathophysiology of hypertension. We hypothesize that treating hypertension with colchicine on top of standard therapy, will decrease pulse wave velocity (PWV), left ventricular mass, cardiac ...
Adam Femerling Langhoff, Niklas Dyrby Johansen, Marie Frimodt‐Møller, Ahmad Sajadieh, Tina Ken Schramm, Thomas A. Jepps, Tor Biering‐Sørensen   +6 more
wiley   +1 more source

Advancing Minimally Invasive Mitral Valve Surgery: Early Outcomes of a Total Endoscopic 2D and 3D Approach. [PDF]

J Cardiovasc Dev Dis
Savini C, Fiorentino M, Sangiorgi D, Calvi S, Costantino A, Tenti E, Mikus E.   +6 more
europepmc   +1 more source

Modular Upgrade From AVEIR VR to AVEIR DR: A Leadless Dual‐Chamber Pacing Experience in Central Asia

Pacing and Clinical Electrophysiology, Volume 49, Issue 6, Page 808-810, June 2026.
ABSTRACT Leadless pacing systems have evolved toward modular configurations that enable staged restoration of atrioventricular (AV) synchrony without transvenous leads. Real‐world experience with a sequential upgrade from AVEIR VR to a dual‐chamber AVEIR DR system remains limited.
Ayan Abdrakhmanov, Gaziza Marat, Elmira Yessimbekova, Zhanasyl Suleymen   +3 more
wiley   +1 more source

Correction: Survival Analysis of Minimally Invasive Mitral Valve Surgery Versus Conventional Median Sternotomy in the United States. [PDF]

Cureus
Tungjitviboonkun S.
europepmc   +1 more source